Since 2015, RNA has provided valuation, transactional and strategic advisory support services to over 300 clients in almost 1,700 client engagements totaling over $282 billion in asset and transaction value.
Our clients include early-stage venture capital-backed companies, private equity-backed growth companies, publicly traded small and mid-cap companies and their investors.
Our clients typically come to us for advisory research, analysis, valuation and transactional support when they need capital for growth, to plan for strategic transactions (IPOs, M&A, financings) and independent legal opinions re asset valuations when seeking partnerships with third parties.
Discover how we create value for our clients across the life science, healthcare and technology ecosystem: